Clinical phenotype and GNPTAB gene mutation spectrum analysis of Chinese patients with mucolipidosis type II α/β
Frontiers in Medicine · 21.07.2026 · 13
DOI: 10.3389/fmed.2026.1895262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 21.07.2026. Verfasst von Xiaoming Gan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical General Ward, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key La…. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Mucolipidosis type II α/β (ML II α/β) is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GNPTAB gene, leading to GlcNAc-1-phosphotransferase deficiency and subsequent accumulation of intracellular toxic substances. This study aimed to systematically describe the clinical spectrum and mutational characteristics of Chinese patients with ML II α / β to facilitate early diagnosis and provide ethnicity-specific data.
Methods
Whole-exome sequencing (WES) was performed on a new proband, and a comprehensive literature review was conducted, summarizing a total of 56 Chinese cases (including 1 new case).
Results
All patients presented with skeletal deformities (100%), 96.4% had coarse facial features, 94.6% had developmental delay, and the median age at diagnosis was 17.5 months. The new proband carried compound heterozygous non-sense mutations NM_024312.4:c.2455G>T (p.Glu819*) and NM_024312.4:c.1123C>T (p.Arg375*) and died of respiratory failure at 27 months of age. Notably, NM_024312.4:c.1090C>T (p.Arg364*) was the most common mutation (found in 39.3% of patients), associated with typical skeletal abnormalities and early death. Cardiac abnormalities (16.1%) and pulmonary complications (12.5%) were common comorbidities.
Conclusion
This study identified a unique mutational hotspot in Chinese patients with ML II α/β and revealed a severe phenotype with poor prognosis, primarily resulting in death from respiratory failure. These findings are beneficial for clinical diagnosis, genetic counseling, and targeted molecular screening of this disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical General Ward, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, International Science and…
Zitieren
APA
Gan, X., Li, J., & Cao, J. (2026). Clinical phenotype and GNPTAB gene mutation spectrum analysis of Chinese patients with mucolipidosis type II α/β. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1895262
Vancouver
Gan X, Li J, Cao J. Clinical phenotype and GNPTAB gene mutation spectrum analysis of Chinese patients with mucolipidosis type II α/β. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1895262
BibTeX
@article{Gan2026,
author = {Gan, Xiaoming and Li, Jieling and Cao, Jie},
title = {Clinical phenotype and GNPTAB gene mutation spectrum analysis of Chinese patients with mucolipidosis type II α/β},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1895262}
}
EUVIMED